@article{AOL5566,
author = {Jonathan Weiss and Tera Mayer and Noah Brown and Ryan A. Wilcox},
title = {PD-L1 expression and response to nivolumab in a case of relapsed/refractory lymphomatoid granulomatosis},
journal = {Annals of Lymphoma},
volume = {3},
number = {0},
year = {2019},
keywords = {},
abstract = {A 54 years old gentleman presented with lymphomatoid granulomatosis (LyG), an EBV-driven lymphoproliferative disorder associated with angiocentric invasion and expansion of EBV positive B cells. He ultimately developed biopsy-confirmed recurrent disease, despite treatment with immunochemotherapy. A biopsy demonstrated PD-L1 expression, and he underwent treatment with nivolumab, achieving a complete response. Our experience further supports ongoing clinical trials investigating PD-L1/PD-1 blockade in LyG and EBV-associated lymphomas.},
issn = {2616-2695}, url = {https://aol.amegroups.org/article/view/5566}
}